Infinity Pharmaceuticals reported $283K in Gross Profit on Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
TG Therapeutics TGTX:US USD 77K 15K
Amgen AMGN:US USD 5.09B 28M
AstraZeneca AZN:LN USD 8.7B 168M
Bristol Myers Squibb BMY:US USD 8.89B 21M
Eisai 4523:JP JPY 140.84B 11.6B
Eli Lilly And LLY:US USD 5.75B 391.2M
Gilead Sciences GILD:US USD 5.99B 346M
GlaxoSmithKline GSK:LN GBP 5.2B 244M
Infinity Pharmaceuticals INFI:US USD 283K 11K
Johnson & Johnson JNJ:US USD 15.94B 56M
Novartis NOVN:VX USD 9.16B 21M
Pfizer PFE:US USD 14.47B 2.08B
Roche Holding ROG:VX 22.04B 696M
Seattle Genetics SGEN:US USD 419.94M 17.76M
Vascular Biogenics VBLT:US USD 48K 370K
YTE INCY:US USD 872.94M 98.92M